Palo Alto – February 13, 2018 – According to data from IPO Vital Signs and PitchBook, Cooley is the #1 law firm for VC-backed IPOs across all industries in the past 10 years. Additionally, Cooley ranked #1 for issuer-side IPOs across all industries, VC-backed IPOs across all industries, and all tech & life sciences IPOs last year. In 2017, Cooley advised on 136 completed capital markets transactions, including 30 IPOs.
“2017 was a stellar year for capital markets, and it is a privilege being able to partner with many of the most innovative companies in the world, as well as the leading investment banks advising them, as they go public,” said Cooley partner Charlie Kim, co-chair of the Cooley’s capital markets practice alongside partner David Peinsipp. “At Cooley, it’s all about the team. And our deep-rooted commitment to operating as a true team across offices on every IPO is the foundation of our success.”
In the last six months, Cooley advised on a host of IPOs for elite businesses, including tech companies Aquantia, MongoDB, Roku, SendGrid and Stitch Fix and life sciences companies Apellis, Armo, Erytech, Nightstar, NuCana, OptiNose, OrthoPediatrics and Zealand Pharma.
“Our clients are driving innovation, providing novel solutions addressing everything from real estate to significant unmet medical needs,” Peinsipp added. “It’s exciting being able to play a part in helping them access the public markets and accelerate that innovation.”
About Cooley LLP
Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.
Cooley has 900+ lawyers across 13 offices in the United States, China and Europe.